FDA to Act on Benlysta, Rare New Drug for Lupus
More like this
- Increasing lupus cases coincide with Benlysta approval
- New Coagulant Bypasses Clotting Dysfunction in Hemophilia
- Myalept Approved for Treatment of Disorders Marked by Loss of Body Fat
- The 'Heartbreak of Psoriasis' Has Met Its Match!
- With a Favorable Side Effect Profile, Tecfidera Gains the FDA’s Approval